Koyfin Home > Directory > Health Care > Gilead Sciences Inc > EV / EBITDA (ltm)

Gilead Sciences Inc EV / EBITDA (ltm) Chart (GILD)

Gilead Sciences Inc annual/quarterly EV / EBITDA (ltm) from 2010 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Gilead Sciences Inc EV / EBITDA (ltm) for the quarter ending October 10, 2020 was 14.54 a 0.15% increase of 0.02 year over year
  • Gilead Sciences Inc EV / EBITDA (ltm) for the last 12 months ending October 10, 2020 was 14.54 a 0.15% increase of 0.02 year over year
  • Gilead Sciences Inc Annual EV / EBITDA (ltm) for 2020 was 14.54 a 0.71% increase of 0.10 from 2019
  • Gilead Sciences Inc Annual EV / EBITDA (ltm) for 2020 was 14.44 a -0.53% decrease of -0.08 from 2019
  • Gilead Sciences Inc Annual EV / EBITDA (ltm) for 2020 was 14.52 a -0.03% decrease of 0.00 from 2019
Other Valuation Metrics:
  • Gilead Sciences Inc Market Cap for the quarter ending June 06, 2018 was $92,110m a -14.87% decrease of -13,696m year over year
  • Gilead Sciences Inc Price / Book for the quarter ending June 06, 2018 was 4.47 a -4.33% decrease of -0.19 year over year
  • Gilead Sciences Inc Enterprise Value for the quarter ending June 06, 2018 was $96,545m a -14.87% decrease of -14,361m year over year
View Chart On Koyfin

Quarterly GILD EV / EBITDA (ltm) Data

10/202014.54
10/202014.44
10/202014.52
10/202014.52
10/202014.84
10/202015.06
10/202015.30
10/202015.40
10/202015.42
10/202015.26

Annual GILD EV / EBITDA (ltm) Data

202014.54
202014.44
202014.52
202014.52
202014.84
202015.06
202015.30
202015.40
202015.42
202015.26